Pharmaceutical - Women's Health, Ligand Pharmaceuticals

Filter

Popular Filters

Ligand enters global license deal for women's health product

23-07-2013

Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

FDA accepts NDA filings from Pfizer/Ligand and Actelion; Bayer submits Alpharadin

16-12-2012

The US Food and Drug Administration accepted for review a New Drug Application from pharma behemoth Pfizer…

AlgetaAlpharadinBayerbazedoxifeneBiotechnologyConjugated EstrogensLigand PharmaceuticalsNorth AmericaOncologyOpsumitPfizerPharmaceuticalRegulationRespiratory and PulmonaryWomen's Health

Back to top